A Multicentre, Randomized, Double-blind, Allopurinol Controlled Study to Evaluate the Efficacy and Safety of SHR4640 in Subjects With Gout
Clinical trial NCT04956432 · COMPLETED
Trial details
- NCT number
- NCT04956432
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-15
- Primary completion
- 2023-12-13
- Enrollment
- 779
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.